From an experimental perspective, the long latency and variable incidence of mammary tumors among untreated female gene rats limits the practical utility of studying ich a such tumors as models of human disease. Jsing Genotoxic agents such as dimethylbenz(a)-Irma anthracene (DMBA), N-methyl-Nivita-nitrosourea (MNU), and 3-methylcholan-)f the threne (MCA) are among the most comthose monly used compounds to elicit mammary lving gland tumors in rodents. These agents are thought to act as initiators within the context of the multistage model of carcinogenesis. Tumor promotion in mammary tissue mary may be hormonally mediated because the dent expression of tumorigenicity following initis the ation with such genotoxic agents is deternines mined, at least in part, by age-related nma-endocrine kinetics. n the In mice, tumors induced by such comHiotic pounds have a long latency and require ,tinct multiple exposures. In contrast, such ences tumors can be elicited in rats after a single rats, exposure during a critical period in postnances tal development and have a much reduced nflu-latency period. The incidence and number ttion, of chemically induced tumors vary with e tis-dose and route of exposure and between different strains of rats administered identiLctive cal doses by identical routes. Although there e dif-are certain anatomic, histologic, and develds of opmental similarities between the mammaevi-ry glands of rats and humans, there is little 
Relevance for Risk Assessment
The impetus for the review by Russo (8) . The uncertainty in our understanding of the relationships between the estrogen receptor and its various agonistic and antagonistic ligands is illustrative of the complexity of this issue. For example, the responses of cells bearing mutated estrogen receptors may be stimulated by tamoxifen but inhibited by estradiol (9 
